MetaCap

Organigram Global (OGI) vs Retension Pharmaceuticals (RTSN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Retension Pharmaceuticals is the larger company by market cap ($87.6 million vs $82.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OGI-39.21%RTSN-0.19%
+60%+8%-44%
Oct 9, 20261 yearNov 20, 2026
OGI-39.21%RTSN-0.19%
+49%+3%-43%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OGI versus RTSN key metrics
MetricOGIRTSN
Share price$0.583$10.51
Market cap$82.27M$87.57M
1-day change-7.40%-19.22%
YTD return-65.30%—
1-year return-60.61%—
5-year return-93.25%—
P/E ratio (TTM)1.36—
Forward P/E27.76—
EPS (TTM)$0.43$-2.61
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2.24$18.64
52-week low$0.583$9.23
Distance from 52-week high-73.97%-43.62%
Analyst consensusstrong_buystrong_buy
Avg. price target upside—+391.63%
Average volume567.77K144.93K
Shares outstanding141.11M8.33M
Employees1,13912
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Organigram Global

OGI stock →

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.

Health Care · Biotechnology: Pharmaceutical Preparations · 1,139 employees

About Retension Pharmaceuticals

RTSN stock →

Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees

OGI vs RTSN FAQ

Which is bigger, Organigram Global or Retension Pharmaceuticals?

Retension Pharmaceuticals (RTSN) is larger, with a market capitalization of $87.57M compared with $82.27M for Organigram Global (OGI).

Are Organigram Global and Retension Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons